Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer

著者: Fabrice Denis, Ethan Basch, Anne-Lise Septans, Jaafar Bennouna, T. Urban, Amylou C. Dueck, Christophe Letellier - JAMA 2019 被引用: 567

This study reports 2-year survival outcomes among patients with advanced nonprogressive stage IIA to IV lung cancer randomized to symptom monitoring during chemotherapy via web-based patient-reported outcomes vs standard scheduled imaging after treatment to detect symptomatic recurrence.